Enzymatica AB (publ)

OM:ENZY Stock Report

Market Cap: SEK 347.4m

Enzymatica Management

Management criteria checks 3/4

Enzymatica's CEO is Claus Egstrand, appointed in Sep 2021, has a tenure of 3.33 years. total yearly compensation is SEK4.70M, comprised of 99.1% salary and 0.9% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth SEK449.90K. The average tenure of the management team and the board of directors is 3.7 years and 8.1 years respectively.

Key information

Claus Egstrand

Chief executive officer

SEK 4.7m

Total compensation

CEO salary percentage99.1%
CEO tenure3.3yrs
CEO ownership0.1%
Management average tenure3.7yrs
Board average tenure8.1yrs

Recent management updates

Recent updates

Is Enzymatica (STO:ENZY) Using Too Much Debt?

Jul 20
Is Enzymatica (STO:ENZY) Using Too Much Debt?

Is Enzymatica (STO:ENZY) Using Too Much Debt?

Jul 22
Is Enzymatica (STO:ENZY) Using Too Much Debt?

Is Enzymatica (STO:ENZY) Weighed On By Its Debt Load?

Feb 18
Is Enzymatica (STO:ENZY) Weighed On By Its Debt Load?

Estimating The Fair Value Of Enzymatica AB (STO:ENZY)

Jan 12
Estimating The Fair Value Of Enzymatica AB (STO:ENZY)

Things Look Grim For Enzymatica AB (STO:ENZY) After Today's Downgrade

Jul 20
Things Look Grim For Enzymatica AB (STO:ENZY) After Today's Downgrade

CEO Compensation Analysis

How has Claus Egstrand's remuneration changed compared to Enzymatica's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 54m

Jun 30 2024n/an/a

-SEK 56m

Mar 31 2024n/an/a

-SEK 54m

Dec 31 2023SEK 5mSEK 5m

-SEK 50m

Sep 30 2023n/an/a

-SEK 58m

Jun 30 2023n/an/a

-SEK 62m

Mar 31 2023n/an/a

-SEK 66m

Dec 31 2022SEK 5mSEK 5m

-SEK 69m

Sep 30 2022n/an/a

-SEK 57m

Jun 30 2022n/an/a

-SEK 50m

Mar 31 2022n/an/a

-SEK 55m

Dec 31 2021SEK 1mSEK 1m

-SEK 45m

Compensation vs Market: Claus's total compensation ($USD420.99K) is above average for companies of similar size in the Swedish market ($USD229.87K).

Compensation vs Earnings: Claus's compensation has been consistent with company performance over the past year.

CEO

Claus Egstrand (63 yo)

3.3yrs

Tenure

SEK 4,698,000

Compensation

Mr. Claus Egstrand serves as Chief Executive Officer at Enzymatica AB since September 09, 2021. He was the Chief Operating Officer at Enzymatica AB since March 2019 until September 09, 2021 and served as i...

Leadership Team

NamePositionTenureCompensationOwnership
Claus Egstrand
Chief Executive Officer3.3yrsSEK 4.70m0.13%
SEK 449.9k
Therese Filmersson
CFO & Deputy CEO7yrsSEK 1.32m0.19%
SEK 644.0k
Malin Richter
Director of Operations4yrsno datano data
Chris Czyrko
Commercial Director3yrsno data0.017%
SEK 59.6k

3.7yrs

Average Tenure

55.5yo

Average Age

Experienced Management: ENZY's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Bengt Baron
Independent Chairman8.1yrsSEK 500.00k1.65%
SEK 5.7m
Mats Andersson
Director8.1yrsSEK 225.00k16.87%
SEK 58.6m
Louise Nicolin
Independent Director8.1yrsSEK 275.00k0.11%
SEK 368.6k
Gudmundur Palmason
Independent Director8.9yrsSEK 225.00k2.08%
SEK 7.2m
Helene Willberg
Independent Director3.7yrsSEK 400.00k0.11%
SEK 368.3k
Moa Fransson
Independent Director2.8yrsSEK 225.00kno data

8.1yrs

Average Tenure

56.5yo

Average Age

Experienced Board: ENZY's board of directors are considered experienced (8.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 18:37
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Enzymatica AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jakob LembkeABG Sundal Collier Sponsored
Peter SelleiPenser Access
Maria Karlsson OsipovaPenser Access